Brivaracetam as adjunctive treatment for uncontrolled partial epilepsy in adults: A phase <scp>III</scp> randomized, double‐blind, placebo‐controlled trial
Summary Purpose Brivaracetam ( BRV ) is a novel high‐affinity synaptic vesicle protein 2A ligand currently being investigated for the treatment of epilepsy. The purpose of this phase III study was to evaluate the efficacy and safety/tolerability of adjunctive BRV in adults with uncontrolled partial‐...
Kaydedildi:
Asıl Yazarlar: | , , , , , |
---|---|
Materyal Türü: | Artigo |
Dil: | İngilizce |
Baskı/Yayın Bilgisi: |
2013
|
Online Erişim: | https://doi.org/10.1111/epi.12433 https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/epi.12433 |
Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|
İlk yorumlayan siz olun!